Seeking Alpha

Elan (ELN) shares jump +4.6% premarket after Acorda Therapeutics (ACOR) announces positive...

Elan (ELN) shares jump +4.6% premarket after Acorda Therapeutics (ACOR) announces positive prescriber response for its AMPYRA treatment for MS patients. The drug is manufactured by Elan in a supply agreement with Acorda.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)